Ultrasound guided sclerotherapy is a minimally invasive, relatively painless outpatient procedure used to treat chronic veinous insufficiency (CVI). It involves using an ultrasound guided needle and injecting a medication into the vein to chemically ablate (shut down) the vein.
The chemical used in sclerotherapy is an FDA approved agent usually injected as a foam-like substance. Once injected, it works to shrink and collapse the vein, causing blood to reroute to healthier, more functional veins.
During the procedure, the vein to be injected is localized using ultrasound guidance. The medication is then injected into highly specific parts of the vein, and the agent emulsifies under close supervision.
The procedure only takes about 15 minutes to complete and is performed with local anesthesia.
Compression stockings are worn for one week after the procedure and patients can resume their normal activities immediately after the procedure.
Patients are encouraged to participate in light movement and activity immediately following the procedure, and discouraged from standing still for long periods of time or participating in strenuous activity, such as heavy lifting, for at least one week following the procedure. Walking at least 30 minutes per day is also recommended immediately following ultrasound guided sclerotherapy.
Ultrasound guided sclerotherapy is generally used in patients whose dysfunctional veins are too close to the surface of the skin for radiofrequency ablation. To determine if you are an ideal candidate, schedule a consultation with one of our vein specialists.
If it is determined that ultrasound guided sclerotherapy is best for you, one of our highly experienced interventional radiologists will discuss the procedure and address any questions or concerns you may have.
Side effects associated with ultrasound guided sclerotherapy are minimal and include: